Saturday, October 03, 2015 11:40:12 PM
Not much new, however some anecdotal insights ......
- They filed financials on time , in fact early. This may indicate a concerted effort to meet the requirements for OTC chill removal or just more effort at attempting corporate transparency for shareholders.
This has not occurred for several years. A marked positive event , regardless of the weakness of the info within.
- There's $22,000 of new capitalized Patent Expense indicated. This would infer that patent work was done during this period , or at a minimum , bills paid related to patents. A sign of activity, and another positive I would think
-Cash position improved a little. Insignificant IMO.
Additional baby steps, but steps nonetheless
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM